FindTrial
Sign In

Clinical STUDY ON THE EFFECT OF VAMANA KARMA FOLLOWED BY SHATAPUSHPA TAILA PRATIMARSHA NASYA, KANASHATAHVADI KASHAYA AND NASHTA PUSHPANTAKA RASA ORALLYIN ARTHAVA KSHAYA DUE TO PCOD

OPEN LABEL SINGLE ARM STUDY ON THE EFFECT OF VAMANA KARMA FOLLOWED BY SHATAPUSHPA TAILA PRATIMARSHA NASYA, KANASHATAHVADI KASHAYA AND NASHTA PUSHPANTAKA RASA IN ARTHAVA KSHAYA DUE TO PCOD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031234
Enrollment
30
Registered
2021-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Vamana karma: â?¢Vamana karma will be administered in the following steps- Chitrakadi vati will be used for Deepana and Pachana in the dose of 2 tablets three times a day before food wi

Sponsors

SKAMC Bangalore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients in between 18 to 35 years of age Patients with signs and symptoms of Arthava kshaya due to PCOD only. Patients fit for Vamana karma

Exclusion criteria

Exclusion criteria: Patients with Arthava kshaya secondary to Hypothyroidism, Primary ovarian failure. Patients with Hyperprolactenaemia. Patients with congenital anomalies of reproductive system Patients having any other systemic illness.

Design outcomes

Primary

MeasureTime frame
.Reduction in weight .Regularity in menstrual cycle Timepoint: Follow up is done after 3months—

Secondary

MeasureTime frame
. Reduction of cyst in USG . normalcy of FSH and LH hormoneTimepoint: Assessment is done after 3months—

Countries

India

Contacts

Public ContactDr Deepa M Nelaguddad

RGUHS Bangalore

dr.anupama.v@gmail.com9845442660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026